We identified transcriptional regulators, including IRF1 and STAT2, that have not been previously implicated in FXTAS pathogenesis, that warrant future study, particularly given some reports of immune-mediated disorders preceding FXTAS symptoms in individuals with the premutation (54). The gene discussed is STAT2; the disease is fragile X-associated tremor/ataxia syndrome.